Skip to main content
. Author manuscript; available in PMC: 2020 Jan 10.
Published in final edited form as: Int J Pharm. 2018 Nov 5;554:212–223. doi: 10.1016/j.ijpharm.2018.11.011

Figure 7.

Figure 7.

Hemocompatibility of UPE NPs and coating substrates. (A) Blood clotting profiles of NPs and substrates were similar to that of saline control. (B) Hemolysis for the NPs and coating substrates was also observed to be less than 2%. n=8 replicates were used for these studies.